Therapeutic Solutions International Inc (TSOI):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Therapeutic Solutions International Inc (TSOI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8212
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:32
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Therapeutic Solutions International Inc (Therapeutic Solutions) is a pharmaceutical company that offers supplements. The company offers products such as DermalStilbene, NanoStilbene and ProJuvenol. Its ProJuvenol consists of anti-aging ingredients which helps for a healthy functionality for everyday living and promotes cellular rejuvenation. The company offers products in forms of syrups and capsules. Therapeutic Solutions also offers anti-ageing vitalization dietary supplement which increases the bone density, optimize hormone levels for body shaping, reduce fat, improve muscle tone, increase libido and sexual function, and decrease symptoms of stress and anxiety. It markets its products in the US and abroad. Therapeutic Solutions is headquartered in Oceanside, California?, the US.

Therapeutic Solutions International Inc (TSOI) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Therapeutic Solutions International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Therapeutic Solutions International Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Therapeutic Solutions International Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Therapeutic Solutions International Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Therapeutic Solutions International Inc, Medical Devices Deals, 2012 to YTD 2018 9
Therapeutic Solutions International Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Therapeutic Solutions International Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Therapeutic Solutions Raises Funds through Venture Financing 11
Therapeutic Solutions International Raises USD0.1 Million in Venture Financing 12
Partnerships 13
Therapeutic Solutions Enters Into Distribution Agreement With S4S 13
Licensing Agreements 14
Emvolio Signs Patent Licensing Agreement with Therapeutics Solutions International 14
Emvolio Enters into Licensing Agreement with Therapeutic Solutions International 15
Emvolio Enters into Licensing Agreement with Therapeutics Solutions International for innaMune 16
Emvolio Enters into Licensing Agreement with Therapeutics Solutions International 17
Emvolio Enters into Patent Licensing Agreement with Therapeutics Solutions International 18
MolecuVax Enters into Licensing Agreement with UniVax 19
MolecuVax Enters into Licensing Agreement with Therapeutic Solutions International 20
Therapeutic Solutions International Enters into Licensing Agreement with Gustave Roussy 21
OmniBiome Therapeutics Enters into Licensing Agreement with Therapeutic Solutions International for the Treatment or Prevention of Pregnancy Complications 22
Therapeutic Solutions International Inc – Key Competitors 23
Therapeutic Solutions International Inc – Key Employees 24
Therapeutic Solutions International Inc – Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Recent Developments 26
Corporate Communications 26
Jun 18, 2018: Therapeutic Solutions International Announces the Appointment of James Veltmeyer, MD as Chief Medical Officer 26
May 09, 2018: Therapeutic Solutions International Announces the Appointment of Nassir Azimi, MD, to Science Board 27
Feb 27, 2018: Therapeutic Solutions International Recruits Top Doctor of San Diego to Scientific Advisory Board 28
Oct 17, 2017: Therapeutic Solutions International strengthens the TSOI Scientific Advisory Board with the Appointment of Pablo A. Guzman, MD 29
May 01, 2017: Therapeutic Solutions International Announces Appointment of Dr. Thomas E. Ichim to its Subsidiary Emvolio 30
Product News 31
Jun 25, 2018: Therapeutic Solutions International releases “IsoStilbene” Injectable formulation of Pterostilbene under granted patent for augmentation of immunotherapy and targeting of cancer stem cells 31
Appendix 32
Methodology 32
About GlobalData 32
Contact Us 32
Disclaimer 32

List of Tables
Therapeutic Solutions International Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Therapeutic Solutions International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Therapeutic Solutions International Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Therapeutic Solutions International Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Therapeutic Solutions International Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Therapeutic Solutions International Inc, Medical Devices Deals, 2012 to YTD 2018 9
Therapeutic Solutions International Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Therapeutic Solutions Raises Funds through Venture Financing 11
Therapeutic Solutions International Raises USD0.1 Million in Venture Financing 12
Therapeutic Solutions Enters Into Distribution Agreement With S4S 13
Emvolio Signs Patent Licensing Agreement with Therapeutics Solutions International 14
Emvolio Enters into Licensing Agreement with Therapeutic Solutions International 15
Emvolio Enters into Licensing Agreement with Therapeutics Solutions International for innaMune 16
Emvolio Enters into Licensing Agreement with Therapeutics Solutions International 17
Emvolio Enters into Patent Licensing Agreement with Therapeutics Solutions International 18
MolecuVax Enters into Licensing Agreement with UniVax 19
MolecuVax Enters into Licensing Agreement with Therapeutic Solutions International 20
Therapeutic Solutions International Enters into Licensing Agreement with Gustave Roussy 21
OmniBiome Therapeutics Enters into Licensing Agreement with Therapeutic Solutions International for the Treatment or Prevention of Pregnancy Complications 22
Therapeutic Solutions International Inc, Key Competitors 23
Therapeutic Solutions International Inc, Key Employees 24
Therapeutic Solutions International Inc, Subsidiaries 25

List of Figures
Therapeutic Solutions International Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Therapeutic Solutions International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Therapeutic Solutions International Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Therapeutic Solutions International Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Therapeutic Solutions International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Therapeutic Solutions International Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Therapeutic Solutions International Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Therapeutic Solutions International Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Therapeutic Solutions International Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Therapeutic Solutions International Inc (TSOI):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • New China Life Insurance Company Ltd.:戦略・SWOT・企業財務分析
    New China Life Insurance Company Ltd. - Strategy, SWOT and Corporate Finance Report Summary New China Life Insurance Company Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Riyad Bank:企業の戦略・SWOT・財務情報
    Riyad Bank - Strategy, SWOT and Corporate Finance Report Summary Riyad Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Pall Corp-医療機器分野:企業M&A・提携分析
    Summary Pall Corp (Pall), a subsidiary of Danaher Corporation, is a supplier of filtration, separation and purification products and technologies to remove solid, liquid and gaseous contaminants from liquids and gases. Its major products include biochemicals, bioreactors, breathers, canisters, cartr …
  • Severn Trent Plc:企業の戦略・SWOT・財務分析
    Severn Trent Plc - Strategy, SWOT and Corporate Finance Report Summary Severn Trent Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • BSN medical GmbH:企業の戦略的SWOT分析
    BSN medical GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Bristol-Myers Squibb Company:企業の戦略・SWOT・財務情報
    Bristol-Myers Squibb Company - Strategy, SWOT and Corporate Finance Report Summary Bristol-Myers Squibb Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Genedata AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Genedata AG (Genedata) is a healthcare technology company that transforms data into software solutions. The company delivers enterprise solutions for data analytics that streamline research and development workflows and improve research productivity. Its products include genedata biologics, …
  • Headwater Exploration Inc (HWX):企業の財務・戦略的SWOT分析
    Summary Headwater Exploration Inc (Headwater), formerly Corridor Resources Inc, is an oil and gas company. It is engaged in exploring, producing and developing of petroleum and natural gas products. The company’s core operating areas include McCully Field in New Brunswick, Anticosti Island in Quebec …
  • Powerflute Oy:企業の戦略的SWOT分析
    Powerflute Oy - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • The Juroku Bank Ltd:企業の戦略・SWOT・財務情報
    The Juroku Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary The Juroku Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Trader Joe’s Company:企業の戦略・SWOT・財務情報
    Trader Joe's Company - Strategy, SWOT and Corporate Finance Report Summary Trader Joe's Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Danaher Corp (DHR):医療機器:M&Aディール及び事業提携情報
    Summary Danaher Corp (Danaher) is a medical technology company which designs, manufactures and markets medical, professional, commercial and industrial products and services. It offers a wide range of testing instruments, communications solutions, water quality systems, medical diagnostics solutions …
  • Sempra Energy:企業の戦略・SWOT・財務情報
    Sempra Energy - Strategy, SWOT and Corporate Finance Report Summary Sempra Energy - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • ALS Limited (ALQ)-石油・ガス分野:企業M&A・提携分析
    Summary ALS Limited (ALS), formerly, Campbell Brothers Limited is a diversified testing service provider. The company provides testing services in the areas of minerals, life sciences, energy and industrial. It provides chemical and laboratory services, technical testing and inspection services supp …
  • Seguradoras Unidas, S.A.:企業の戦略・SWOT・財務分析
    Seguradoras Unidas, S.A. - Strategy, SWOT and Corporate Finance Report Summary Seguradoras Unidas, S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Imvescor Restaurant Group Inc:戦略・SWOT・企業財務分析
    Imvescor Restaurant Group Inc - Strategy, SWOT and Corporate Finance Report Summary Imvescor Restaurant Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • De La Rue Plc (DLAR):企業の財務・戦略的SWOT分析
    De La Rue Plc (DLAR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Golden Star Resources Ltd:企業の戦略・SWOT・財務分析
    Golden Star Resources Ltd - Strategy, SWOT and Corporate Finance Report Summary Golden Star Resources Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Shenzhen Neptunus Interlong Bio-Technique Co Ltd (8329):企業の財務・戦略的SWOT分析
    Summary Shenzhen Neptunus Interlong Bio-Technique Co Ltd (Neptunus) manufactures and distributes gene engineering drugs and preventive biological products. The company’s products include recombinant human interferon a-2b injection, used to treat hepatitis and cancers; recombinant human interleukin-2 …
  • Gulf Keystone Petroleum Ltd (GKP):企業の財務・戦略的SWOT分析
    Summary Gulf Keystone Petroleum Ltd (Gulf Keystone) is an oil and gas company that offers operation and production of oil and natural gas reserves. The company operates working interests in the Republic of Algeria and the Kurdistan Region of Northern Iraq. Its Kurdistan Region of Iraq operates produ …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆